In a recent review, we described the identification as well as the characterization of a completely new atypical opioid receptor with exclusive damaging regulatory Houses toward opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can also be a https://busterm505iho2.ourcodeblog.com/profile